Compound details
Euphorbia factor Ti2
| Compound ID | CDAMM02594 |
|---|---|
| Common name | Euphorbia factor Ti2 | IUPAC name | [14-acetyloxy-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] deca-2,4,6-trienoate |
| Molecular formula | C32H42O7 |
| Retention time | 13.17 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 561.277 | Theoretical mz | 561.282 |
| Error | 9.83 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.5042 |
| Inchi key | HZIPPZZEKIZPCY-ZVJIWEFKNA-N |
|---|---|
| Smiles | O=C(OC12C(OC(=O)C)C(C)C3(O)C4C=C(C(=O)C4CC(=CC3C1C2(C)C)CO)C)C=CC=CC=CCCC |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P24723 | PRKCH | Protein kinase C eta | T40149 | SwissTargetPrediction |
| P05771 | PRKCB | Protein kinase C beta | T40276 | SwissTargetPrediction |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SwissTargetPrediction |
| Q05655 | PRKCD | Protein kinase C delta | T44861 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| Q9HBA0 | TRPV4 | Transient receptor potential cation channel subfamily V member 4 | T64213 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T40149 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P24723 | PRKCH |
| T40276 | DI0123 | Diffuse large B-cell lymphoma | [ICD-11: 2A81] | P05771 | PRKCB |
| T40276 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P05771 | PRKCB |
| T40276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P05771 | PRKCB |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |
| T44861 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q05655 | PRKCD |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T64213 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q9HBA0 | TRPV4 |
| T64213 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q9HBA0 | TRPV4 |
| T64213 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | Q9HBA0 | TRPV4 |